Sara Jane Cromer MD
Diabetes, Lipid Metabolism
Assistant in Medicine, Massachusetts General Hospital; Instructor, Harvard Medical School
Join to View Full Profile
50 Blossom StBoston, MA 02114
Phone+1 617-726-8720
Dr. Cromer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sara Jane Cromer is an endocrinologist in Boston, MA and is affiliated with Massachusetts General Hospital. She received her medical degree from Baylor College of Medicine and has been in practice 2 years. She also speaks multiple languages, including Spanish. She specializes in diabetes and lipid metabolism.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2018 - 2021
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2015 - 2018
Baylor College of MedicineClass of 2015, MD, with Honors; Care of the Underserved Track; Outstanding Senior in Internal Medicine
Rice UniversityBS, BA, Biochemistry and Cell Biology, French Studies, Cum Laude, 2007 - 2011
Certifications & Licensure
MA State Medical License 2018 - 2026
NY State Medical License 2017 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Joseph N. Muschel Award in recognition for “kindness, empathy, and integrity" Columbia Internal Medicine Residency, 2018
- Junior Resident Award for Excellence in Clinical Education Columbia Internal Medicine Residency, 2017
- SGIM Clinical Vignette Competition Finalist Society for General Internal Medicine, 2017
- Join now to see all
Publications & Presentations
PubMed
- Adapting a Text Messaging Intervention to Improve Diabetes Medication Adherence in a Spanish-Speaking Population: Qualitative Study.Jacqueline Seiglie, Seth Tobolsky, Ricaurte Crespo Trevino, Lluvia Cordova, Sara Cromer
JMIR Human Factors. 2025-05-01 - 1 citationsComparing Insulin Against Glucagon-Like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors, and Sodium-Glucose Cotransporter 2 Inhibitors on 5-Year Inciden...Xuan Wang, Anna M Plantinga, Xin Xiong, Sara J Cromer, Clara-Lea Bonzel
JMIR Diabetes. 2024-10-22 - Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study.Wajd Alkabbani, Karine Suissa, Kristine D Gu, Sara J Cromer, Julie M Paik
BMJ. 2024-10-22
Journal Articles
- Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control.Thomas H, Diamond J, Vieco A, Chaudhuri S, Shinnar E, Cromer S, Perel P, Mensah GA, Narula J, Johnson CO, Roth GA, Moran AE, Glob Heart
- Untreated Renal Failure and Metabolic Acidosis During Pregnancy: A Unique Insight Into Natural History of the Disease: A Case ReportCromer SJ, Sargent KS, Clark S, Eppes CS, J Repro Med
Authored Content
- Prioritization of GLP1-RA and Dual Agonists in an Era of ShortagesJuly 2024
- GRADE: A Comparative Effectiveness Trial for Type 2 DiabetesJuly 2021
Press Mentions
SGLT2 Inhibitors May Offer More Cardioprotective Benefits Than GLP-1s for Older AdultsFebruary 3rd, 2025
Professional Memberships
- ASBMRMember
- SGIMMember
- CMDAMember
- Member
- Member
Other Languages
- Spanish
External Links
- Research Gatehttps://www.researchgate.net/profile/Sara_Cromer
- Orcidhttp://orcid.org/0000-0002-4924-2049
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
